- Categories:About Us
- Time of issue:2019-05-24 00:00:00
Shanghai Global R&D Centre and Nanjing GMP Production Platform
Currently the company has a 2,300㎡ GMP production platform, a 4,600㎡ R&D platform, and almost 10,000㎡ of commercial space in Nanjing. It also has a 1,750㎡ R&D platform in Zhangjiang Hi-tech Park ( Shanghai) and a global R&D center of approximately 57,000 square meters under construction in Shanghai Pilot Free Trade Zone.
R&D Platform & GMP Pilot Plant
IASO BIO has 7,000 square meters faclities of R&D platform and GMP Pilot Plant , which allows high-capacity manufacturing of plasmid and lentivirus(2000 patients/year) and CAR-T products (500 patients/year).
Office in Nanjing, Shanghai
IASO BIO provides safe, comfortable and harmonious working environment，committing to growing together with it's employees.